📰 Randomized Trial News
Page 2 - Randomized Trial News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Randomized Trial. Real-time updates on events, politics, business and more.
February 27, 2024
<ul> <li>In the GENERATE study, 90% of those who viewed an online genetic education program chose to be tested for inherited predisposition to pancreatic cancer</li> <li>Participation in the online genetic education program did not increase participants&#39; concerns about developing cancer</li> </ul>
January 8, 2024
Results of the 76-week trial suggest that a treat-and-extend aflibercept regimen yields similar functional and anatomic outcomes as fixed dosing every 8 weeks among patients with nAMD.
December 17, 2023
Ready to unlock your full potential in the pool? Here are the best strength training exercises for swimmers to unleash the beast on your personal best times.
December 11, 2023
By combining the administration of psychedelic compounds with therapeutic support, ketamine-assisted therapy is proving remarkable efficacy in treating mental health conditions.
December 8, 2023
Supplements, vitamins, and other natural ADHD remedies can augment medication to improve focus and cognitive function. Learn more.
November 27, 2023
The first day of the 109th Scientific Sessions and Annual Meeting of the Radiological Society of North America, RSNA 2023, delivered an engaging and highly-anticipated range of education and scientific sessions, technical exhibit floor demonstrations and news developments. Highlights from day one are summarized in this snapshot summary of several key programs and professional insights.
November 16, 2023
/PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that five new presentations related to Peyronies disease, or PD, and XIAFLEX® (collagenase...
November 9, 2023
Reported positive preliminary Phase 2 data on additional patients for HB-200 in combination with pembrolizumab in the 1st-line setting for advanced HPV16+ head and neck cancer; data reinforce strong objective response rate and disease control rate reported in Q2 2023; randomized trial expected to start in 2024 Published peer-reviewed preclinical data, in collaboration with Gilead Sciences, for HB-400 program in The Journal of Infectious Disease Recruitment ongoing for two Phase 1 clinical trials
October 20, 2023
Late-breaking trials will be presented during the main sessions and highlighted during press conferences scheduled for Oct. 24, 25 and 26
September 27, 2023
A liquid diet replaces solid food with liquids, such as meal shakes & smoothies. But does a liquid diet for weight loss really work in 2023?